
This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.
Societal CDMO subject matter experts explore trends in pharmaceutical drug development and highlight capabilities of the US-based pharmaceutical CDMO company.
Interviews featuring:






